Azenta inc

美股醫療保健

AZTA 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,若以價值投資為目標,已經有長期投資部位可能需陸續減碼

AZTA 近期報酬表現

-1.33%

Azenta inc

-0.98%

同產業平均

-0.22%

S&P500

與 AZTA 同產業的標的表現

  • TECH Bio-techne corp
    價值 5 分趨勢 2 分波段 2 分籌碼 3 分股利 3 分
    查看更多

AZTA 公司資訊

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company's segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.

AZTA 股價